ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,805Medicare Part D Prescriptions Filled, Including Refills

Rank: 351 out of 2343

$648K Total Retail Price of All Prescriptions

Rank: 389 out of 2343

541 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 11,080 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 511 507 1 7
FUROSEMIDE 488 482 2 6
WARFARIN SODIUM 402 381 3 8
SIMVASTATIN 399 375 4 1
LEVOTHYROXINE SODIUM 345 312 5 2
FELODIPINE ER 285 285 6 116
AMLODIPINE BESYLATE 276 275 7 5
LISINOPRIL 227 205 8 3
ATORVASTATIN CALCIUM 224 218 9 10
DONEPEZIL HCL 208 208 10 21
OMEPRAZOLE 199 167 11 4
TRAMADOL HCL 192 174 12 25
HYDROCODONE-ACETAMINOPHEN 180 177 S3 13 13
POTASSIUM CHLORIDE 177 170 14 18
GLYBURIDE 175 175 R 15 62
HYDROCHLOROTHIAZIDE 173 167 16 11
LOSARTAN POTASSIUM 170 147 17 19
PANTOPRAZOLE SODIUM 169 161 18 22
DIGOXIN 167 165 19 35
MELOXICAM 154 146 20 68
CLOPIDOGREL 154 150 20 26
ALENDRONATE SODIUM 147 141 22 28
PREDNISONE 144 140 23 37
PAROXETINE HCL 133 129 24 66
ISOSORBIDE MONONITRATE ER 124 121 25 32
PLAVIX 121 116 26 38
TAMSULOSIN HCL 113 110 27 29
TRIAMTERENE-HCTZ 113 112 27 57
DIOVAN 111 111 29 23
METOPROLOL SUCCINATE 109 109 30 14
INSULIN SYRINGE 106 103 31 102
AZITHROMYCIN 101 89 32 39
DILTIAZEM 24HR ER 96 86 33 76
ENALAPRIL MALEATE 93 93 34 58
METFORMIN HCL 91 81 35 9
SYNTHROID 89 89 36 40
ESCITALOPRAM OXALATE 87 87 37 55
CITALOPRAM HBR 80 78 38 17
CIPROFLOXACIN HCL 79 70 39 72
NOVOLIN N 77 63 40 300
NEXIUM 73 68 41 33
NOVOLIN R 70 62 42 227
GABAPENTIN 70 69 42 16
COUMADIN 68 68 44 216
ATENOLOL 68 54 44 12
CELEBREX 66 64 46 71
MIRTAZAPINE 66 66 46 41
LANTUS SOLOSTAR 64 64 48 101
ZOLPIDEM TARTRATE 62 49 49 24
FAMOTIDINE 61 51 50 60
VOLTAREN 61 60 50 175
LIPITOR 58 54 52 78
SERTRALINE HCL 57 55 53 20
MECLIZINE HCL 56 56 54 103
RANITIDINE HCL 56 44 54 43
ADVAIR DISKUS 56 54 54 34
IBUPROFEN 54 49 57 75
TRIAMCINOLONE ACETONIDE 53 44 58 137
HUMULIN N 53 53 58 343
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.